217 related articles for article (PubMed ID: 25453468)
21. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
Meyer KC; Cardoni A; Xiang ZZ
J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049
[TBL] [Abstract][Full Text] [Related]
22. Assessment of CCL2 and CXCL8 chemokines in serum, bronchoalveolar lavage fluid and lung tissue samples from dogs affected with canine idiopathic pulmonary fibrosis.
Roels E; Krafft E; Farnir F; Holopainen S; Laurila HP; Rajamäki MM; Day MJ; Antoine N; Pirottin D; Clercx C
Vet J; 2015 Oct; 206(1):75-82. PubMed ID: 26231926
[TBL] [Abstract][Full Text] [Related]
23. Early pulmonary inflammation in infants with cystic fibrosis.
Khan TZ; Wagener JS; Bost T; Martinez J; Accurso FJ; Riches DW
Am J Respir Crit Care Med; 1995 Apr; 151(4):1075-82. PubMed ID: 7697234
[TBL] [Abstract][Full Text] [Related]
24. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis.
Tsao FH; Meyer KC; Chen X; Rosenthal NS; Hu J
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):120-8. PubMed ID: 9448053
[TBL] [Abstract][Full Text] [Related]
25. Physiological concentration of calcium inhibits elastase-induced cleavage of a functional recombinant fragment of surfactant protein D.
Duvoix A; Mackay RM; Henderson N; McGreal E; Postle A; Reid K; Clark H
Immunobiology; 2011; 216(1-2):72-9. PubMed ID: 20378199
[TBL] [Abstract][Full Text] [Related]
26. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
Bergsson G; Reeves EP; McNally P; Chotirmall SH; Greene CM; Greally P; Murphy P; O'Neill SJ; McElvaney NG
J Immunol; 2009 Jul; 183(1):543-51. PubMed ID: 19542465
[TBL] [Abstract][Full Text] [Related]
27. Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis.
Pittman JE; Wylie KM; Akers K; Storch GA; Hatch J; Quante J; Frayman KB; Clarke N; Davis M; Stick SM; Hall GL; Montgomery G; Ranganathan S; Davis SD; Ferkol TW;
Ann Am Thorac Soc; 2017 Oct; 14(10):1548-1555. PubMed ID: 28708417
[TBL] [Abstract][Full Text] [Related]
28. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs.
Hartl D; Starosta V; Maier K; Beck-Speier I; Rebhan C; Becker BF; Latzin P; Fischer R; Ratjen F; Huber RM; Rietschel E; Krauss-Etschmann S; Griese M
Free Radic Biol Med; 2005 Aug; 39(4):463-72. PubMed ID: 16043018
[TBL] [Abstract][Full Text] [Related]
29. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
[TBL] [Abstract][Full Text] [Related]
30. Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
von Bredow C; Birrer P; Griese M
Eur Respir J; 2001 Apr; 17(4):716-22. PubMed ID: 11401069
[TBL] [Abstract][Full Text] [Related]
31. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis.
Stites SW; Plautz MW; Bailey K; O'Brien-Ladner AR; Wesselius LJ
Am J Respir Crit Care Med; 1999 Sep; 160(3):796-801. PubMed ID: 10471599
[TBL] [Abstract][Full Text] [Related]
32. Airway remodelling in children with cystic fibrosis.
Hilliard TN; Regamey N; Shute JK; Nicholson AG; Alton EW; Bush A; Davies JC
Thorax; 2007 Dec; 62(12):1074-80. PubMed ID: 17526676
[TBL] [Abstract][Full Text] [Related]
33. Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study.
Wojtczak HA; Kerby GS; Wagener JS; Copenhaver SC; Gotlin RW; Riches DW; Accurso FJ
Pediatr Pulmonol; 2001 Oct; 32(4):293-302. PubMed ID: 11568990
[TBL] [Abstract][Full Text] [Related]
34. Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis.
Sagel SD; Sontag MK; Accurso FJ
Pediatr Pulmonol; 2009 Apr; 44(4):402-9. PubMed ID: 19283840
[TBL] [Abstract][Full Text] [Related]
35. Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells.
Bergamini G; Cigana C; Sorio C; Della Peruta M; Pompella A; Corti A; Huaux FA; Leal T; Assael BM; Melotti P
Am J Respir Cell Mol Biol; 2009 Aug; 41(2):199-206. PubMed ID: 19097986
[TBL] [Abstract][Full Text] [Related]
36. Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis.
Useckaite Z; Ward MP; Trappe A; Reilly R; Lennon J; Davage H; Matallanas D; Cassidy H; Dillon ET; Brennan K; Doyle SL; Carter S; Donnelly S; Linnane B; McKone EF; McNally P; Coppinger JA
Thorax; 2020 Jun; 75(6):449-458. PubMed ID: 32265339
[TBL] [Abstract][Full Text] [Related]
37. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis.
Muhlebach MS; Noah TL
Am J Respir Crit Care Med; 2002 Apr; 165(7):911-5. PubMed ID: 11934713
[TBL] [Abstract][Full Text] [Related]
38. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.
Konstan MW; Hilliard KA; Norvell TM; Berger M
Am J Respir Crit Care Med; 1994 Aug; 150(2):448-54. PubMed ID: 8049828
[TBL] [Abstract][Full Text] [Related]
39. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
40. Detection of bile acids in bronchoalveolar lavage fluid defines the inflammatory and microbial landscape of the lower airways in infants with cystic fibrosis.
Caparrós-Martín JA; Saladie M; Agudelo-Romero SP; Reen FJ; Ware RS; Sly PD; Stick SM; O'Gara F;
Microbiome; 2023 Jun; 11(1):132. PubMed ID: 37312128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
